This company has been marked as potentially delisted and may not be actively trading. Range Cancer Therapeutics ETF (CNCR) Holdings Add Compare Share Share Holdings Stock AnalysisHoldingsRatingsShort InterestTrendsBuy This Stock Top 50 CNCR HoldingsRankCompanyCurrent PriceWeightShares Held1SMMTSummit Therapeutics$27.90+13.1%2.72%6,3282FATEFate Therapeutics$1.31+5.6%2.27%131,8303BNTXBioNTech$104.94+2.5%1.87%1,2634SDGRSchrödinger$25.29+1.6%1.77%5,3685ARVNArvinas$7.72+6.8%1.72%14,6426FHTXFoghorn Therapeutics$4.24+1.9%1.68%27,6937TSVT2seventy bio$5.00+0.4%1.66%25,7358HCMHUTCHMED$15.00+1.4%1.65%8,4149JANXJanux Therapeutics$32.88+2.6%1.65%4,04310EXELExelixis$39.60+1.8%1.64%3,441 Get the Latest News and Ratings for CNCR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Range Cancer Therapeutics ETF and its competitors with MarketBeat's FREE daily newsletter. 11NUVBNuvation Bio$2.46+8.4%1.64%60,95112SNDXSyndax Pharmaceuticals$13.73-0.7%1.64%9,76913IMCRImmunocore$30.46+1.0%1.63%4,24114ZYMEZymeworks$12.96+0.6%1.63%10,12615IDYAIDEAYA Biosciences$20.93+2.2%1.62%6,65916DNAGinkgo Bioworks$7.04+1.1%1.61%16,39517ERASErasca$1.58+6.0%1.60%87,25118IPHAInnate Pharma$2.26+2.3%1.60%62,75219ITOSiTeos Therapeutics$7.77+3.6%1.60%17,30820GMABGenmab A/S$21.48+2.6%1.59%6,12421STROSutro Biopharma$1.10+2.8%1.59%136,62322RVMDRevolution Medicines$40.72+0.2%1.58%3,25523NUVLNuvalent$77.46+1.6%1.55%1,65424TYRATyra Biosciences$10.86+3.6%1.54%11,86125BPMCBlueprint Medicines$104.64+5.4%1.53%1,38326CGEMCullinan Therapeutics$8.79+3.2%1.53%14,10727IBRXImmunityBio$2.54+2.0%1.52%43,77628LYELLyell Immunopharma$0.46-1.9%1.52%246,34929PGENPrecigen$1.57+1.3%1.50%71,56630IMTXImmatics$5.23+4.4%1.49%25,58031LEGNLegend Biotech$33.17-2.3%1.49%3,35832KYMRKymera Therapeutics$35.28+2.1%1.47%3,69333RCUSArcus Biosciences$9.12+5.8%1.46%13,92234MRUSMerus$44.19-2.8%1.46%2,69835RLAYRelay Therapeutics$3.25-1.2%1.46%36,29336CMPXCompass Therapeutics$1.89+3.8%1.45%54,20737VORVor Biopharma$0.66+0.1%1.45%148,07338ACLXArcellx$65.55+0.0%1.44%1,75139INBXInhibrx$12.15-1.4%1.44%9,13840KURAKura Oncology$6.47-0.3%1.44%17,474The Man I Turn to In Times Like This (Ad)A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.Market chaos? Hear Tilson’s take now41ALLOAllogene Therapeutics$1.70+0.6%1.43%68,85842BCYCBicycle Therapeutics$9.30+2.4%1.43%12,76443REGNRegeneron Pharmaceuticals$605.61+2.6%1.43%18844YMABY-mAbs Therapeutics$4.41+7.3%1.43%26,76245DAWNDay One Biopharmaceuticals$7.93+4.1%1.41%14,69346IOVAIovance Biotherapeutics$3.50+5.1%1.40%34,06147ELVNEnliven Therapeutics$20.51+3.3%1.39%6,05548XNCRXencor$11.26+3.7%1.38%9,81449MRKMerck & Co., Inc.$83.14-0.1%1.37%1,34450NRIXNurix Therapeutics$11.27+1.0%1.37%9,145 Geographic ExposureUnited States95.0%Netherlands3.2%Currency ExposureUSD100.1%Sector ExposureHealth Care93.2%Biotechnology2.6%Information Technology1.7%Chemicals1.5%Industry ExposureBiotechnology92.4%Pharmaceuticals3.3%IT Services1.7%Chemicals1.5%SubIndustry ExposureBiotechnology83.5%Pharmaceuticals6.7%Internet Services & Infrastructure1.7%Specialty Chemicals1.5%Coupon Exposure4-61.1%Maturity Exposure5-101.1% Related Companies and Tools Related Companies JPMorgan Healthcare Leaders ETF Portfolio ProShares UltraShort Nasdaq Biotechnology Portfolio First Trust Nasdaq Pharmaceuticals ETF Portfolio Horizon Kinetics Medical ETF Portfolio Global X HealthTech ETF Portfolio Invesco Nasdaq Biotechnology ETF Portfolio ProShares Ultra Nasdaq Biotechnology Portfolio F/m Emerald Life Sciences Innovation ETF Portfolio Invesco Dorsey Wright Healthcare Momentum ETF Portfolio Invesco S&P SmallCap Health Care ETF Portfolio This page (NASDAQ:CNCR) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredU.S. Stock Market Now on Verge of CollapseThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Range Cancer Therapeutics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Range Cancer Therapeutics ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CNCR Stock Free CNCR Stock Alerts